Been doing some researchI thought I'd share with the board:
Abbvie Inc (ABBV) is a biotech company I recently came across that has an FDA approved synthetic THC drug. Market cap of ~114 billion and revenues of ~33 billion. It also has a pretty high dividend over 5%. It looks like it's been consolidating around $77 after a run over $123+. Looks like a pretty solid addition to a weed portfolio. I'm looking to add myself once the downtrend appears to be over. Hoping for $60s.